INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H102. A total of 78 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 3.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2013 | $725,000 | – | 250,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 408,352 | $1,360,000 | 0.70% |
| Round Table Services, LLC | 150,000 | $500,000 | 0.55% |
| Broadfin Capital, LLC | 1,250,000 | $4,163,000 | 0.40% |
| EAM Investors, LLC | 303,509 | $1,011,000 | 0.18% |
| Orbimed Advisors | 3,987,000 | $13,277,000 | 0.16% |
| EMERALD ADVISERS, LLC | 733,180 | $2,441,000 | 0.14% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 366,820 | $1,222,000 | 0.12% |
| CTC Alternative Strategies, Ltd. | 50,900 | $169,497,000 | 0.10% |
| Plancorp, LLC | 30,000 | $100,000 | 0.07% |
| TradeLink Global Equity LLC | 13,400 | $45,000 | 0.06% |